BPC-157 vs TB-500: Which Healing Peptide for Your Research?
A detailed comparison of two of the most researched recovery peptides. Mechanisms, applications, and when to use each in your research protocols.
Overview
BPC-157 and TB-500 are two of the most widely studied peptides in tissue repair and recovery research. While they share the common goal of promoting healing, they work through fundamentally different mechanisms and are suited to different research applications.
This guide breaks down the science behind each peptide, compares their key properties, and explains when researchers might choose one over the other — or combine both.
What Is BPC-157?
BPC-157 (Body Protection Compound-157) is a pentadecapeptide consisting of 15 amino acids. It is derived from a protective protein found in human gastric juice.
Research Focus Areas: - Tendon, ligament, and muscle healing - Gastrointestinal tract protection and repair - Wound healing acceleration - Angiogenesis (new blood vessel formation) - Neuroprotective effects
BPC-157 has been studied in over 100 research papers for its regenerative properties. It works primarily by upregulating growth factor expression (VEGF, EGF) and modulating the nitric oxide system.
Key Research Findings: - Accelerated healing of severed Achilles tendons in rodent models - Protection against NSAID-induced gastric damage - Promotion of mucosal healing in inflammatory bowel models - Counteraction of organ damage from various toxic agents
What Is TB-500?
TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring 43-amino acid peptide present in virtually all human cells. It is the primary G-actin sequestering molecule, playing a fundamental role in cell motility.
Research Focus Areas: - Cell migration to sites of injury - Angiogenesis and new blood vessel growth - Reduction of inflammation and fibrosis - Cardiac tissue repair - Hair follicle stem cell stimulation
TB-500 works by binding to actin monomers, promoting cell migration and proliferation at injury sites. It also downregulates inflammatory cytokines and has been studied for its anti-fibrotic properties.
Key Research Findings: - Improved cardiac function after induced heart injury in rodent models - Enhanced dermal wound closure rates - Reduction of inflammatory markers in multiple tissue types - Promotion of hair growth in dermal papilla cell studies
Side-by-Side Comparison
| Property | BPC-157 | TB-500 | |---|---|---| | Amino Acids | 15 | 43 | | Origin | Human gastric juice | Thymus gland (Thymosin Beta-4) | | Primary Mechanism | Growth factor upregulation, NO modulation | Actin binding, cell migration | | Key Strength | Gut and tendon repair | Systemic tissue repair, anti-inflammation | | Research Volume | 100+ published papers | 50+ published papers | | Stability | Highly stable in gastric conditions | Standard peptide stability | | Typical Research Dose | 5-10mg vials | 5-10mg vials | | Peptify Price | BPC-157 5mg from £14.99, 10mg from £26.99 | TB-500 5mg from £24.99, 10mg from £38.99 |
When to Choose BPC-157
BPC-157 is the preferred choice in research protocols focused on:
- Localised tissue repair (tendons, ligaments, muscles) - Gastrointestinal healing and protection - Studies involving NSAID-induced damage - Wound healing at specific injury sites - Neuroprotection studies
Its high stability in gastric conditions makes it particularly valuable for GI tract research, a property TB-500 does not share.
When to Choose TB-500
TB-500 is the preferred choice in research protocols focused on:
- Systemic tissue repair across multiple sites - Cardiac repair and cardiovascular research - Anti-inflammatory studies - Cell migration and motility research - Dermatological and hair growth studies
Its mechanism of action (actin regulation, cell migration) makes it particularly suited to whole-body recovery protocols where inflammation reduction is a primary goal.
Stacking BPC-157 and TB-500
Many researchers investigate BPC-157 and TB-500 together due to their complementary mechanisms. BPC-157 promotes localised healing through growth factor pathways, while TB-500 facilitates systemic repair through cell migration and anti-inflammatory action.
This combination is one of the most popular research stacks in the recovery peptide space. Peptify offers both peptides individually and as a pre-blended BPC-157 + TB-500 Blend 20mg for convenience.
The blend provides both peptides in a single vial at a combined price that is lower than purchasing each separately.
Frequently Asked Questions
Can BPC-157 and TB-500 be used together in research?
Yes. Many researchers study these peptides in combination due to their complementary healing mechanisms. Peptify offers a pre-blended BPC-157 + TB-500 20mg vial for this purpose.
Which peptide has more published research?
BPC-157 has a larger body of published research (100+ papers) compared to TB-500 (50+ papers), though both are well-studied in preclinical models.
What purity should I look for?
99%+ HPLC-verified purity is recommended for research-grade peptides. All Peptify peptides meet this standard with independent third-party verification.
Ready to Start Your Research?
Browse our full range of 99%+ purity, COA-verified research peptides.
Browse Products